Backed by an excellent compliance history and track record, Albany Molecular Research Inc.'s (AMRI) worldwide manufacturing facilities are equipped for Phase I through commercial manufacturing, with capabilities in small- and large-scale manufacturing. Facilities comprise cGMP and non-GMP laboratories, an experienced staff dedicated to cGMP synthesis, and an aggregate 270,000L of global capacity.
Strengths of our small-scale manufacturing platform include clinical API manufacturing and clinical drug product manufacturing, which includes oral drug products and sterile fill and finish.
During 2010, AMRI invested in its formulation services and CTM manufacturing offerings by adding capabilities in the areas of excipient blending, wet and dry granulation, and tableting.
Aseptic fill and finish services in the area of process scale-up includes experience with liposomes, proteins, and suspensions. The company’s syringe filling and stoppering services feature a five-head, on-line vacuum fill and stoppering syringe filler.